Cellectis bioresearch launches VizuCELL cell lines for live cell imaging

Paris (France), April, 17th 2013 - Cellectis bioresearch, a subsidiary of Cellectis Group (Alternext: ALCLS), the genome engineering specialist, announces the launch of VizuCELL cell lines, a tool for live cell imaging.

Paris (France), April, 17th 2013 - Cellectis bioresearch, a subsidiary of Cellectis Group (Alternext: ALCLS), the genome engineering specialist, announces the launch of VizuCELL cell lines, a tool for live cell imaging.

As live cell imaging has become a requisite analytical tool in most cell biology laboratories, Cellectis bioresearch has developed VizuCELL cell lines for biomedical research and cell biology.

VizuCELL cell lines offer an exceptional tool to study temporal and spatial dynamic processes in living cells in order to get critical insights into morphological changes and physiological events in real time.

VizuCELL are generated by utilizing our proprietary TALEN™ technology to tag endogenous genes with a fluorescent signal controlled by the endogenous promoter.

The VizuCELL product line comprises the most popular cell lines in imaging (HeLa and  U-2 OS), which are large cells growing in monolayers, therefore enabling unambiguously visualization of cell organelles and the cytoskeleton.

VizuCELL is suitable for non-invasive long-term monitoring. Due to stable endogenous protein expression the obtained information mirrors models closer to real life. VizuCELL simplifies the experimental with ready-to go imaging for a faster and cost effective workflow.